TY  - JOUR
N1  - Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/6038)
PB  - Center for Tech and Media Research
N2  - During the COVID-19 pandemic, laboratory biomarkers have become essential tools for evaluating disease severity, predicting complications, and determining the need for intensive therapy. This article presents a scientific and analytical synthesis of retrospective data from 350 hospitalized patients with PCR-confirmed SARS-CoV-2 infection.
Key laboratory indicators with high prognostic significance were identified: lymphopenia, neutrophil-to-lymphocyte ratio (N/L), C-reactive protein (CRP), lactate dehydrogenase (LDH), fibrinogen, D-dimer, and platelet parameters. The study established that combined immuno-inflammatory and coagulopathic abnormalities shape an integral pathogenetic profile of severe COVID-19. Particular attention is given to the U-shaped relationship between fibrinogen levels (<2.0 g/L or >9.0 g/L) and mortality risk, as well as the strong association of elevated D-dimer with thrombotic complications and multi-organ failure.
These findings underscore the necessity of continuous laboratory monitoring and highlight the importance of biomarker-based personalized patient management.
TI  - LABORATORY PREDICTORS OF SEVERE COVID-19: A SCIENTIFIC AND ANALYTICAL REVIEW OF RETROSPECTIVE STUDY DATA
JF  - Multidisciplinary Journal of Science and Technology
UR  - https://mjstjournal.com/index.php/mjst/article/view/6038
Y1  - 2025/12/08/
KW  - COVID-19; laboratory biomarkers; fibrinogen; D-dimer; lymphopenia
ID  - arxiv64257
AV  - none
A1  - Alimova, Umidakhon
ER  -